Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Altamira Therapeutics H1 2024 EPS $(2.11) Up From $(21.55) YoY

Author: Benzinga Newsdesk | September 24, 2024 07:05am
Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(2.11) per share. This is a 90.21 percent increase over losses of $(21.55) per share from the same period last year.

Posted In: CYTO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist